Literature DB >> 7035349

Current management of childhood acute lymphocytic leukemia.

H Ekert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7035349     DOI: 10.1007/bf02822298

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  38 in total

1.  Intellectual abilities among survivors of childhood leukaemia as a function of CNS irradiation.

Authors:  C Eiser
Journal:  Arch Dis Child       Date:  1978-05       Impact factor: 3.791

2.  Prevention of central nervous system leukemia by irradiation.

Authors:  H O Hustu; R J Aur; M S Verzosa; J V Simone; D Pinkel
Journal:  Cancer       Date:  1973-09       Impact factor: 6.860

3.  Lymphocytic leukemia in children: prognostic significance of clinical and laboratory findings at time of diagnosis.

Authors:  R L Heideman; J M Falletta; N Mukhopadhyay; D J Fernbach
Journal:  J Pediatr       Date:  1978-04       Impact factor: 4.406

4.  Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study Group.

Authors:  M E Nesbit; H N Sather; L L Robison; J Ortega; P S Littman; G J D'Angio; G D Hammond
Journal:  Lancet       Date:  1981-02-28       Impact factor: 79.321

5.  Immunologic classification of acute lymphoblastic leukemia. Implications for normal lymphoid differentiation.

Authors:  K A Foon; R J Billing; P I Terasaki; M J Cline
Journal:  Blood       Date:  1980-12       Impact factor: 22.113

6.  Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results.

Authors:  S E Sallan; B M Cammita; J R Cassady; D G Nathan; E Frei
Journal:  Blood       Date:  1978-03       Impact factor: 22.113

7.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

8.  Cyclophosphamide-asparaginase- vincristine-prednisone induction therapy in childhood acute lymphocytic and nonlymphocytic leukemia.

Authors:  D M Komp; S L George; J Falletta; V J Land; K A Starling; G B Humphrey; J Lowman
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

9.  Immunological conditioning of bone marrow for autotransplantation in childhood acute lymphoblastic leukaemia.

Authors:  B Netzel; R J Haas; H Rodt; H J Kolb; S Thierfelder
Journal:  Lancet       Date:  1980-06-21       Impact factor: 79.321

10.  Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma.

Authors:  L J Rubinstein; M M Herman; T F Long; J R Wilbur
Journal:  Cancer       Date:  1975-02       Impact factor: 6.860

View more
  3 in total

1.  Evaluation of different induction regimens in children with acute lymphocytic leukemia.

Authors:  V P Choudhry; L S Arya
Journal:  Indian J Pediatr       Date:  1988 Sep-Oct       Impact factor: 1.967

2.  Challenges in the management of leukemia in India.

Authors:  V P Choudhry; R K Marwaha
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

3.  Evaluation of prednisolone and vincristine with and without L-asparaginase in acute lymphatic leukemia of childhood.

Authors:  V P Choudhry; R K Marwaha; D P Goyal; A K Sarya
Journal:  Indian J Pediatr       Date:  1983 Nov-Dec       Impact factor: 1.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.